Patterns of patient enrollment in randomized controlled trials

scientific article published on September 2001

Patterns of patient enrollment in randomized controlled trials is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0895-4356(01)00353-5
P698PubMed publication ID11520646

P50authorJohn IoannidisQ6251482
P2093author name stringHaidich AB
P2860cites workReduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study GroupQ28239283
Is recruitment more difficult with a placebo arm in randomised controlled trials? A quasirandomised, interview based studyQ37444348
When to stop a clinical trialQ39361186
Heterogeneity of the baseline risk within patient populations of clinical trials: a proposed evaluation algorithmQ40832107
Changes in clinical trials mandated by the advent of meta-analysisQ40936208
The Rational Use of Therapeutic Drugs in the 21st Century:Important Lessons from Cumulative Meta-analyses of Randomized Control TrialsQ41006977
A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection. The NIAID AIDS Clinical Trials GroupQ41809454
Efficacy of zidovudine and human immunodeficiency virus (HIV) hyperimmune immunoglobulin for reducing perinatal HIV transmission from HIV-infected women with advanced disease: results of Pediatric AIDS Clinical Trials Group protocol 185.Q45751388
Impact of epidemic and individual heterogeneity on the population distribution of disease progression rates. An example from patient populations in trials of human immunodeficiency virus infectionQ45766048
A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials GroupQ45784083
Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious DiseasesQ45853622
Using cost-effectiveness analysis to improve the efficiency of allocating funds to clinical trialsQ52508647
The futility index. An approach to the cost-effective termination of randomized clinical trialsQ52673266
Using economic analysis to determine the resource consequences of choices made in planning clinical trialsQ52681829
Effect of the Statistical Significance of Results on the Time to Completion and Publication of Randomized Efficacy TrialsQ74121809
P433issue9
P921main subjectpatientQ181600
P304page(s)877-883
P577publication date2001-09-01
P1433published inJournal of Clinical EpidemiologyQ6294959
P1476titlePatterns of patient enrollment in randomized controlled trials
P478volume54

Reverse relations

cites work (P2860)
Q33516495A cost-effectiveness analysis of subject recruitment strategies in the HIPAA era: results from a colorectal cancer screening adherence trial
Q47812966A framework for prospectively defining progression rules for internal pilot studies monitoring recruitment
Q50353991A nationwide retrospective study of perioperative chemotherapy for gastroesophageal adenocarcinoma: tolerability, outcome, and prognostic factors.
Q37148467A protocol for a systematic review of non-randomised evaluations of strategies to improve participant recruitment to randomised controlled trials
Q33974581A randomised controlled trial on the effectiveness of bracing patients with idiopathic scoliosis: failure to include patients and lessons to be learnt
Q37053641Attitudes of Patients in Developing Countries Toward Participating in Clinical Trials: A Survey of Saudi Patients Attending Primary Health Care Services
Q40345371Barriers and Strategies for Recruitment of Racial and Ethnic Minorities: Perspectives from Neurological Clinical Research Coordinators
Q34444038Challenges in recruitment to a randomized controlled study of cardiovascular disease reduction in sleep apnea: an analysis of alternative strategies
Q37480195Clear obstacles and hidden challenges: understanding recruiter perspectives in six pragmatic randomised controlled trials
Q39773744Communication, recruitment and enrolment in the preventative and therapeutic phase I clinical trial against HIV/AIDS based on the recombinant HIV-1 Tat protein
Q24800021Determinants of patient recruitment in a multicenter clinical trials group: trends, seasonality and the effect of large studies
Q30855271Developing and evaluating multimedia information resources to improve engagement of children, adolescents, and their parents with trials (TRECA study): Study protocol for a series of linked randomised controlled trials
Q90625346Discontinuation of a randomised controlled trial in general practice due to unsuccessful patient recruitment
Q47685382Early stopping in clinical trials and epidemiologic studies for "futility": conditional power versus sequential analysis
Q60922098Effectiveness of a short video-based educational intervention on factors related to clinical trial participation in adolescents and young adults: a pre-test/post-test design
Q51147914Effects of recruitment strategies and demographic factors on inclusion in a large scale vaccination trial in adults 65 years and older
Q36406088Effort Required in Eligibility Screening for Clinical Trials
Q64117217Enrollment Challenges: Recruiting Men to Weight Loss Interventions
Q55409454Factors influencing the enrollment in randomized controlled trials in orthopedics.
Q37044134Feasibility of Virtual Research Visits in Fox Trial Finder.
Q39589281HElmet therapy Assessment in infants with Deformed Skulls (HEADS): protocol for a randomised controlled trial
Q58696787How can we get Iraq- and Afghanistan-deployed US Veterans to participate in health-related research? Findings from a national focus group study
Q45995387Implementing a prospective study of women seeking abortion in the United States: understanding and overcoming barriers to recruitment.
Q37869586Incomplete reporting of recruitment information in breast cancer trials published between 2003 and 2008
Q92377680Keeping track of all ongoing colorectal cancer trials using a mobile application: Usability and satisfaction results of the Dutch Colorectal Cancer Group Trials application
Q44204184Late-starter sites in randomized controlled trials
Q36483995Learning from failure--rationale and design for a study about discontinuation of randomized trials (DISCO study).
Q37431917Meeting the challenges of recruitment to multicentre, community-based, lifestyle-change trials: a case study of the BeWEL trial
Q41891202Methodological survey of designed uneven randomization trials (DU-RANDOM): a protocol
Q38818772Methods to improve patient recruitment and retention in stroke trials
Q30537000Methods to improve recruitment to randomised controlled trials: Cochrane systematic review and meta-analysis
Q37783680Prospectively screening for eligible patients was inaccurate in predicting patient recruitment of orthopedic randomized trials
Q35626545Recruitment challenges of a multicenter randomized controlled varicocelectomy trial.
Q24236017Strategies to improve recruitment to randomised controlled trials
Q24241074Strategies to improve recruitment to randomised controlled trials
Q50104975Strategies to improve recruitment to randomised trials
Q37336757The use of electronic medical records for recruitment in clinical trials: findings from the Lifestyle Intervention for Treatment of Diabetes trial
Q51419039Use of online recruitment strategies in a randomized trial of cancer survivors
Q77632318Using technology to address recruitment issues in the clinical trial process
Q52010857Who can best recruit to randomized trials? Randomized trial comparing surgeons and nurses recruiting patients to a trial of treatments for localized prostate cancer (the ProtecT study).
Q80192460Women's views regarding participation in a proposed randomized controlled trial of twin delivery

Search more.